Actinium Pharmaceuticals (ATNM) Q2 2025 Earnings

May 9Confirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-0.51
-0.44
-0.38
-0.31

Details

Expected EPS
-0.428
Actual EPS
-0.51
Surprise EPS
-0.08
Surprise Percent
-19.16%

Description

⁨Actinium Pharmaceuticals⁩ (⁦ATNM⁩) has reported earnings of ⁦-0.51⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts